Get more replies from employers
Send a job-specific resume in minutes.
Digital Biotechnologies is seeking a Scientist I to lead and coordinate research experiments advancing our solid-state sequencing platform. You will design and perform nanoscale materials synthesis, characterize interfaces, and build assays in collaboration with cross-disciplinary teams to push toward clinical diagnostics.
The role requires strong microscopy skills (AFM, TEM) and data-driven problem solving, with the ability to communicate complex results to stakeholders and contribute to
Digital Biotechnologies is developing a solid-state single-molecule sequencing platform designed to deliver rapid, affordable, and accessible DNA sequencing in clinical settings. Our vision is a future where DNA sequencing becomes a routine clinical diagnostic—empowering physicians with actionable genetic information whenever and wherever it is needed. Looking ahead, our platform has the potential to expand beyond DNA to RNA and other biomolecules.
We are seeking an exceptional Scientist I to join our growing team. This position will manage, design, and coordinate research-focused experiments that leverage Digital’s novel intellectual property to realize the company’s strategic objectives in fundamental science, health care and business development. Whether designing experiments, generating high-quality data, building new assays, or solving complex technical challenges, your contributions will directly influence the development of a technology with the potential to transform molecular diagnostics.
If you are excited by solving challenging scientific problems, thrive in a collaborative, fast-paced environment, and want your work to have a direct impact on the future of clinical diagnostics, we'd love to hear from you.
$101,600 - $152,400
Help make DNA sequencing a routine clinical diagnostic.
Today, most DNA sequencing requires specialized laboratories, expensive instrumentation, and days to weeks before results reach physicians. While these technologies have transformed biological research and clinical testing, they remain too slow, costly, and operationally complex for many time-sensitive clinical applications. Digital Biotechnologies is changing that.
Achieving this vision requires expertise that spans multiple scientific and engineering disciplines. Our team integrates molecular biology, biochemistry, DNA nanotechnology, solid-state physics, microfabrication, electronics, signal processing, software, and data science to solve one of the most challenging problems in biotechnology. It is this interdisciplinary approach that enables us to develop technologies that would not be possible within any single field alone.
Backed by $15 million in Series A financing following early support from Adaptive Biotechnologies, Digital offers the opportunity to work in a highly collaborative startup environment where every team member plays a meaningful role in shaping both the technology and the company.